Every 10-Q that Corteva, Inc. (CTVA) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CTVA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CTVA filings page.
Corteva reported Q2 2026 net sales of $6,379 million (vs $6,456 million a year earlier) and net income attributable to Corteva of $1,161 million (vs $1,314 million), or diluted EPS of $1.73. For the first six months, net sales were $11,284 million and net income attributable to Corteva was $1,881 million.
Seed generated $7,555 million of year‑to‑date sales, led by North America corn and soybeans, while Crop Protection contributed $3,729 million. Operating cash flow for the first half was negative $3,357 million, reflecting large deferred‑revenue run‑off, working‑capital swings and pension contributions of $1,140 million. Cash and restricted cash totaled $2,619 million, with short‑term borrowings of $3,193 million and $6,000 million of committed credit facilities.
Management approved 2026 restructuring actions (~$80 million of severance) and continues the multi‑year Crop Protection Operations Strategy, expected to incur $750–$815 million of pre‑tax charges through 2028 (of which $674 million is recorded). Corteva also recorded sizable legal and environmental items, including a $610 million settlement with Bayer, PFAS‑related cost‑sharing under a memorandum of understanding, and settlements of Federal Trade Commission and related antitrust lawsuits, contributing to current accrued litigation of $468 million alongside significant indemnification assets.
Corteva, Inc. reported Q3 2025 results with net sales of $2,618 million, up from $2,326 million a year ago. The quarter posted a net loss attributable to Corteva of $320 million and diluted EPS of $-0.47 versus $-0.76 last year, as higher sales were offset by costs and foreign exchange impacts.
Year-to-date, net sales reached $13,491 million and diluted EPS were $2.41 compared to $1.35 in 2024. Operating cash flow was $(969) million, improving from $(2,028) million last year. Cash and cash equivalents were $2,509 million, short‑term borrowings $2,685 million, and long‑term debt $1,688 million at September 30, 2025.
Segments: Seed Q3 sales were $917 million (driven by corn at $586 million), and Crop Protection was $1,701 million. The company continues its Crop Protection Operations Strategy Restructuring Program, expecting $650–$700 million in aggregate pre‑tax charges; $594 million has been recorded inception‑to‑date, with actions expected to be substantially complete by the end of 2026.